Physician profile
Jophin Johnson
NPI 1831725225
$1,002.79
in general payments reported to CMS, 2019-2025
17 companies · $174 in 2025
The $174 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.99 · 2021: $275 · 2022: $170 · 2023: $221 · 2024: $151 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $401.91 | 2022-2025 | Acthar |
| Sanofi-Aventis U.S. LLC | $77.23 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $68.42 | 2021-2025 | Airsupra |
| Sunovion Pharmaceuticals INC. | $64.49 | 2021 | |
| Exact Sciences Corporation | $48.70 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $45.12 | 2022 | |
| Novartis Pharmaceuticals Corporation | $42.53 | 2021 | |
| Abbvie INC. | $42.17 | 2021 | |
| Merck Sharp & Dohme LLC | $34.01 | 2021 | |
| Pfizer INC. | $32.44 | 2022-2024 | |
| Novo Nordisk INC | $30.18 | 2022-2024 | Rybelsus |
| Lilly USA, LLC | $29.87 | 2021-2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $22.47 | 2023 | Shingrix |
| Dexcom, INC. | $18.33 | 2025 | Dexcom G6 Transmitter |
| Avanir Pharmaceuticals, INC. | $18.09 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtus Pharmaceuticals LLC | $14.84 | 2021 | |
| Phadia US INC. | $11.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jophin Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.